Solubility: May be dissolved in DMSO (15 mg/ml, warm)
Appearance: White powder
PubChem CID: 44608289
Scientific Background: Anle138b is an oligomeric aggregation inhibitor that inhibits the formation of pathological prion protein (PrPSc) and α-synuclein aggregates in vitro. Anle138b prevents accumulation of PrPSc in the brain and the spleen. Anle138b exhibits neuroprotective effects in a Parkinson's disease mouse model and improves motor performance in an α-synucleinopathy model.
References: 1. Wagner J. et al. (2013) Acta Neuropathol. 125 (6): 795-813.
Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.